GLP-1s and Gout

Nobody warns people about this and it produces a specific kind of unfairness: you do the thing that will reduce your gout in the long run, and it gives you an attack in month two.

Why it happens

Three mechanisms, all transient, all front-loaded.

Purine release. Rapid weight loss increases cell turnover, and cell breakdown releases purines, which are metabolised to uric acid.

Ketones compete for excretion. In a substantial calorie deficit — and more so on a low-carbohydrate approach — ketone bodies rise, and they compete with urate for the same renal transport. Less urate leaves, so serum urate rises.

Dehydration. This is the one specific to these drugs. Thirst signalling quietens along with appetite, and roughly a fifth of daily water normally arrives inside food you are no longer eating. Less fluid means more concentrated urate. The mechanism is the same one described in the electrolytes rankings.

Any of these can nudge someone over the threshold at which urate crystallises in a joint — flares cluster in the first 3–6 months of rapid loss and become less likely thereafter.

And why it is still worth doing

The long-run direction is clearly favourable. A systematic review of weight loss in people with gout found reductions in serum urate and in flare frequency with loss sustained over 12 months or more. Insulin resistance itself reduces urate excretion, so improving it helps independently of the weight.

So the shape is: risk up briefly, risk down substantially thereafter. The job is getting through the first part without abandoning the second.

The rule people get wrong

There are two rules about urate-lowering therapy and they are frequently swapped.

Do not stop allopurinol or febuxostat during a flare. If you are already established on it, keep taking it. Stopping causes urate to shift again and prolongs the attack. This is standard guidance and it is counter-intuitive enough that people do the opposite.

Do not start it for the first time during a flare. Initiating urate-lowering therapy acutely can precipitate or worsen an attack, which is why it is begun once things have settled, usually with anti-inflammatory cover.

The two rules together: continue what you were on, do not begin something new mid-attack.

Recognising a flare

Usually unmistakable: rapid onset over hours, often overnight, in a single joint — classically the base of the big toe, but frequently the midfoot, ankle or knee, peaking within 12–24 hours. The joint is red, hot, swollen and exquisitely tender, to the point where bedsheets are intolerable.

One important caution. A hot, swollen, painful joint can also be a septic joint, which is an emergency and can look similar. If you have a fever, feel systemically unwell, or this is your first such episode, get assessed rather than assuming. That distinction is not one to make at home.

Also worth separating from the more common joint complaint on these drugs: osteoarthritic knee pain is gradual, mechanical, and improves as weight falls — a different animal entirely, covered in GLP-1s and knee osteoarthritis.

What reduces the risk

Slow the rate of loss. The purine and ketone mechanisms both scale with speed. A slower titration is the same intervention that helps tolerability and reduces gallstone formation — one adjustment, three benefits, and it is the recurring answer on this site for a reason.

Drink properly. Roughly 2 litres a day, deliberately, over 24 hours, because you will not feel thirsty enough to get there.

Go easy on very low carbohydrate approaches in the first months if you are gout-prone, since ketosis is part of the mechanism.

Alcohol, particularly beer. Beer carries both alcohol and purines and has the strongest association with incident gout of the alcoholic drinks. It is also, usefully, something many people find they want less of on this medication — drinking alcohol on a GLP-1.

Review diuretics, ideally every 3–6 months as weight falls. Thiazides raise urate, and they are also the medication most likely to be reduced as your blood pressure falls — so this is worth raising at the review you should be having anyway: blood pressure on a GLP-1.

A flare is not a reason to stop the drug

This is the decision I would most want to influence.

An attack in month two is a treatable, self-limiting event caused by a transient mechanism. Stopping the GLP-1 means giving up the sustained urate reduction that the whole exercise was heading toward, in exchange for avoiding a temporary phase you were already partway through.

Treat the flare, slow the titration to 8 weeks between steps if needed, fix the hydration, and keep going. If flares are recurrent, that is a conversation about starting or optimising urate-lowering therapy — not about abandoning the weight loss.

What to ask for

• A baseline urate before or early in treatment, so later values mean something
• Whether allopurinol or febuxostat is indicated if you have had more than one attack
• A flare plan — what to take, and how quickly to start it, agreed in advance
• Your diuretic reviewed as weight and blood pressure fall
• A slower titration if you are gout-prone, discussed before the first escalation rather than after the first attack